日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting NAT10 alleviates colonic senescence and elderly-onset colitis by disrupting N4-acetylation of DYRK1A.

靶向 NAT10 可破坏 DYRK1A 的 N4-乙酰化,从而缓解结肠衰老和老年性结肠炎。

Chen Jingyu, Xue Meng, Mi Shuyi, Fu Anbo, Chen Wenwen, Sun Yuhao, Xia Shenglong, Ge Qiwei, Luo Jiakai, Yu Qiao, Wang Liangjing, Chen Shujie

A novel feedback loop between DYRK2 and USP28 regulates cancer homeostasis and DNA damage signaling

DYRK2 和 USP28 之间一种新型的反馈回路调节癌症稳态和 DNA 损伤信号传导

Suanes-Cobos, Lucía; Aguilera-Ventura, Irene; Torres-Ramos, Miguel; Serrano-Yubero, Alejandra; Moreno Fernández-Aliseda, Claudia; Fernández, Silvia; Garrido-Rodríguez, Martín; de la Luna, Susana; Prieto-Garcia, Cristian; Diefenbacher, Markus E; Mejías-Pérez, Ernesto; Calzado, Marco A

Induction of cellular senescence by androgen receptor agonist or antagonist is mediated via two novel common DYRK1A-DREAM and cyclin G2 signaling pathways in castration-resistant prostate cancer

在去势抵抗性前列腺癌中,雄激素受体激动剂或拮抗剂诱导细胞衰老是通过两条新的共同信号通路介导的,这两条通路分别是DYRK1A-DREAM和细胞周期蛋白G2信号通路。

Atri Roozbahani, Golnaz; Heidari Horestani, Mehdi; Schindler, Katrin; Kallenbach, Julia; Baniahmad, Aria

The protein kinase DYRK1B is a p53 target gene and functions as a negative feedback regulator of the transcription factor RFX7

蛋白激酶DYRK1B是p53的靶基因,并作为转录因子RFX7的负反馈调节因子发挥作用。

Wilms, Gerrit; Schwandt, Katharina; Düsterhöft, Stefan; Helmich, Philip; Wozniak, Justyna; Kraft, Florian; Kallabis, Sebastian; Meissner, Felix; Becker, Walter

Up-regulation of Minibrain/DYRK1A contributes to macrocephaly and brain overgrowth in a Drosophila model of fragile X syndrome

在脆性X综合征的果蝇模型中,Minibrain/DYRK1A的上调导致巨头畸形和脑过度生长。

Colt, Mark; Gordon, Alicia; Peng, Yi-Jheng; Wu, Ying; Martin, Katherine; Chang, Karen T

The dual fate of DYRK2 in cancer: balancing the light and dark side of tumorigenesis

DYRK2在癌症中的双重命运:平衡肿瘤发生的光明面和黑暗面

Suanes-Cobos, Lucía; Torres-Ramos, Miguel; Aguilera-Ventura, Irene; Serrano-Yubero, Alejandra; Calzado, Marco A

Identification and Validation of an Inhibitor of the Protein Kinases PIM and DYRK.

鉴定和验证蛋白激酶 PIM 和 DYRK 的抑制剂。

Bencze Gyula, Venkataramani Prabhadevi, Elkayam Elad, Rivera Keith D, Garg Ankur, Szabadakai Istvan, Orfi Laszlo, Joshua-Tor Leemor, Pappin Darryl J, Tonks Nicholas K

ZRMQ-22, a novel DYRK1A inhibitor, attenuates neuroinflammation and cognitive impairments in LPS-induced mice: a potential strategy for Alzheimer's disease

ZRMQ-22 是一种新型 DYRK1A 抑制剂,可减轻 LPS 诱导小鼠的神经炎症和认知障碍:一种潜在的阿尔茨海默病治疗策略。

Mengyu Ren,Huanhua Chen,Zhenshu Li,Jiacheng Zhuang,Aizhu Yang,Xiangdong Li,Xinyu Li,Xinpeng Wang,Zonghe Xu,Xianghuan Liu,Jiawen Song,Tianhao Jiang,Zihua Xu,Xudong Gao,Qingchun Zhao

Serial PNA-Transformer-Based Virtual Screening Identifies Nanomolar DYRK1A Inhibitors for Pancreatic Ductal Adenocarcinoma

基于PNA-Transformer的串行虚拟筛选鉴定出用于治疗胰腺导管腺癌的纳摩尔级DYRK1A抑制剂

Zhang, Hongyu; Wang, Ke; Wu, Xiaochuan; Zhou, Rui; Li, Chaofeng; Cai, Xiuyu; Zhuang, Yanyan

A physics-informed graph neural network to approximate docking-based binding affinity for DYRK2 in Alzheimer's drug repurposing

一种基于物理信息的图神经网络,用于近似计算阿尔茨海默病药物再利用中DYRK2的对接结合亲和力

Gider, Veysel; Budak, Cafer